glp 1 drugs for rheumatoid arthritis ACR 2025: GLP-1 Reduce Flares GLP-1s for diabetes reduce rheumatoid
Description
This framework offers a structured way to evaluate how emerging therapies may influence biological aging
10.1073/pnas.1218051109
Khan SS, Brewer LC, Canobbio MM, Cipolla MJ, Grobman WA, Lewey J, et al
GLP-1 receptor agonists should not replace evidence-based lipid management but may complement it in suitable patients
S2CID 252437415
Improvements in Drug Delivery In studies with mice, the research team, led by Bradley Pentelute, a professor of chemistry at MIT, found that their new drug delivery system resulted in sustained weight loss and extended blood sugar management
